Researchers from Toronto’s Women’s College Hospital have presented data at the ENDO 2009 Symposium (in Washington DC) indicating that lower doses of chemotherapy are just as effective as larger doses in adjuvant treatment of thyroid cancer.
Dr. Kumar and colleagues were able to reduce the radiation dose by 70% and maintain the same treatment effect as the standard higher dose.
This innovative study helps establish a safer treatment for thyroid cancer – a disease that has shown increasing incidence over the last two decades. Thyroid cancer occurs approximately three times more frequently in men than women.
Another example of great research being done in Toronto!